Cancer Home > Cabazataxel

Were you looking for information about Cabazitaxel? Cabazataxel is a common misspelling of cabazitaxel.
 
Cabazitaxel (Jevtana®) is a medication licensed to treat prostate cancer. The prescription drug stops the cancer cells from growing and multiplying by interfering with the structures of the cells. It is administered intravenously (through an IV) once every three weeks. Possible side effects may include anemia and low levels of certain white blood cells.
 
(Click Cabazitaxel for more information about how this drug works, its potential side effects, and guidelines on when and how the medication is given. You can also click any of the links in the box to the right for specific information.)
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.